Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$59.54 - $68.01 $232,206 - $265,239
-3,900 Reduced 2.26%
169,000 $10.4 Million
Q1 2022

May 13, 2022

SELL
$57.92 - $72.58 $4.63 Million - $5.81 Million
-80,000 Reduced 31.63%
172,900 $10.3 Million
Q3 2021

Nov 12, 2021

BUY
$67.69 - $73.03 $11.9 Million - $12.8 Million
175,300 Added 225.9%
252,900 $17.7 Million
Q2 2021

Aug 10, 2021

SELL
$63.47 - $69.35 $2.68 Million - $2.93 Million
-42,300 Reduced 35.28%
77,600 $5.34 Million
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $5.22 Million - $5.96 Million
-87,000 Reduced 42.05%
119,900 $7.75 Million
Q3 2020

Nov 12, 2020

BUY
$62.1 - $78.08 $5.31 Million - $6.68 Million
85,500 Added 70.43%
206,900 $13.1 Million
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $3.58 Million - $4.16 Million
49,500 Added 68.85%
121,400 $9.34 Million
Q1 2020

May 14, 2020

SELL
$62.63 - $80.22 $1.57 Million - $2.01 Million
-25,000 Reduced 25.8%
71,900 $5.38 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $11.8 Million - $13 Million
-188,700 Reduced 66.07%
96,900 $6.14 Million
Q2 2019

Aug 14, 2019

SELL
$61.87 - $69.38 $247,480 - $277,520
-4,000 Reduced 1.38%
285,600 $19.3 Million
Q1 2019

May 14, 2019

SELL
$62.53 - $70.05 $1 Million - $1.12 Million
-16,000 Reduced 5.24%
289,600 $18.8 Million
Q4 2018

Feb 12, 2019

SELL
$60.54 - $79.0 $8.43 Million - $11 Million
-139,300 Reduced 31.31%
305,600 $19.1 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $498,960 - $552,440
-7,000 Reduced 1.55%
444,900 $34.4 Million
Q2 2018

Aug 10, 2018

BUY
$64.88 - $75.68 $973,199 - $1.14 Million
15,000 Added 3.43%
451,900 $32 Million
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $946,920 - $1.15 Million
-13,000 Reduced 2.89%
436,900 $32.9 Million
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $569,200 - $668,160
8,000 Added 1.81%
449,900 $32.2 Million
Q3 2017

Nov 13, 2017

BUY
$72.11 - $85.47 $3.24 Million - $3.85 Million
45,000 Added 11.34%
441,900 $35.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
396,900
396,900 $28.1 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Employees Retirement System Of Texas Portfolio

Follow Employees Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Employees Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Employees Retirement System Of Texas with notifications on news.